Intussusceptive Vascular Remodeling Precedes Pathological Neovascularization.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
07 2019
Historique:
entrez: 27 6 2019
pubmed: 27 6 2019
medline: 29 2 2020
Statut: ppublish

Résumé

Objective- Pathological neovascularization is crucial for progression and morbidity of serious diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. While mechanisms of ongoing pathological neovascularization have been extensively studied, the initiating pathological vascular remodeling (PVR) events, which precede neovascularization remains poorly understood. Here, we identify novel molecular and cellular mechanisms of preneovascular PVR, by using the adult choriocapillaris as a model. Approach and Results- Using hypoxia or forced overexpression of VEGF (vascular endothelial growth factor) in the subretinal space to induce PVR in zebrafish and rats respectively, and by analyzing choriocapillaris membranes adjacent to choroidal neovascular lesions from age-related macular degeneration patients, we show that the choriocapillaris undergo robust induction of vascular intussusception and permeability at preneovascular stages of PVR. This PVR response included endothelial cell proliferation, formation of endothelial luminal processes, extensive vesiculation and thickening of the endothelium, degradation of collagen fibers, and splitting of existing extravascular columns. RNA-sequencing established a role for endothelial tight junction disruption, cytoskeletal remodeling, vesicle- and cilium biogenesis in this process. Mechanistically, using genetic gain- and loss-of-function zebrafish models and analysis of primary human choriocapillaris endothelial cells, we determined that HIF (hypoxia-induced factor)-1α-VEGF-A-VEGFR2 signaling was important for hypoxia-induced PVR. Conclusions- Our findings reveal that PVR involving intussusception and splitting of extravascular columns, endothelial proliferation, vesiculation, fenestration, and thickening is induced before neovascularization, suggesting that identifying and targeting these processes may prevent development of advanced neovascular disease in the future. Visual Overview- An online visual overview is available for this article.

Identifiants

pubmed: 31242036
doi: 10.1161/ATVBAHA.118.312190
pmc: PMC6636809
doi:

Substances chimiques

HIF1A protein, human 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
Vascular Endothelial Growth Factor A 0
KDR protein, human EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1402-1418

Références

BMC Dev Biol. 2007 Oct 15;7:114
pubmed: 17937808
Dev Biol. 2017 May 15;425(2):101-108
pubmed: 28365243
Int J Dev Biol. 2011;55(4-5):557-62
pubmed: 21858776
Dev Cell. 2011 Aug 16;21(2):301-14
pubmed: 21802375
Sci Rep. 2016 Aug 26;6:32137
pubmed: 27561355
Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):681-9
pubmed: 25042819
N Engl J Med. 2006 Oct 5;355(14):1419-31
pubmed: 17021318
Nucleic Acids Res. 2010 Apr;38(7):2332-45
pubmed: 20061373
Oncotarget. 2016 Jul 19;7(29):46668-46677
pubmed: 27081695
Curr Opin Ophthalmol. 2015 May;26(3):177-83
pubmed: 25784111
Circulation. 2005 Sep 20;112(12):1813-24
pubmed: 16172288
Nat Immunol. 2003 Dec;4(12):1238-46
pubmed: 14608381
Elife. 2016 Mar 15;5:
pubmed: 26978795
Sci Rep. 2017 Feb 10;7:42546
pubmed: 28186209
Nucleic Acids Res. 2009 Apr;37(7):2249-63
pubmed: 19237398
Thromb Haemost. 2009 Sep;102(3):544-54
pubmed: 19718476
Nat Protoc. 2010 Sep;5(9):1518-34
pubmed: 20725067
J Cell Biol. 2003 Jun 23;161(6):1163-77
pubmed: 12810700
Cell Rep. 2012 Aug 30;2(2):231-41
pubmed: 22884368
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3219-24
pubmed: 17296940
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19485-90
pubmed: 19887629
Curr Biol. 2011 Nov 22;21(22):1942-8
pubmed: 22079115
PLoS One. 2008 Jul 23;3(7):e2748
pubmed: 18648503
Birth Defects Res C Embryo Today. 2011 Jun;93(2):182-93
pubmed: 21671357
J Cell Sci. 2009 Sep 15;122(Pt 18):3294-302
pubmed: 19706683
Nat Rev Immunol. 2007 Jun;7(6):429-42
pubmed: 17525752
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Genes Dev. 2000 Aug 15;14(16):1983-91
pubmed: 10950862
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):654-9
pubmed: 23267058
Mol Cancer. 2003 Jul 09;2:25
pubmed: 12904264
Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18408-13
pubmed: 19822749
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E5944-53
pubmed: 26483474
Dis Model Mech. 2010 Mar-Apr;3(3-4):236-45
pubmed: 20142328
Sci Signal. 2017 Jul 11;10(487):
pubmed: 28698213
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2836-44
pubmed: 21921259
Nat Protoc. 2010 Dec;5(12):1911-8
pubmed: 21127485
Cell Rep. 2014 Oct 23;9(2):504-13
pubmed: 25373898
Angiogenesis. 2011 Sep;14(3):393-405
pubmed: 21744299
Dev Biol. 2002 Aug 15;248(2):307-18
pubmed: 12167406
Nat Rev Endocrinol. 2014 Sep;10(9):530-9
pubmed: 25048037
Science. 2005 Jan 7;307(5706):58-62
pubmed: 15637262
Angiogenesis. 2013 Jan;16(1):123-36
pubmed: 22961440
Development. 2005 Dec;132(23):5199-209
pubmed: 16251212
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2135-41
pubmed: 17656667
PLoS One. 2014 Mar 03;9(3):e90590
pubmed: 24594685
Circ Res. 2000 Feb 18;86(3):286-92
pubmed: 10679480
Genes Dev. 1998 Jan 15;12(2):149-62
pubmed: 9436976
Biochim Biophys Acta. 2016 Jul;1862(7):1291-6
pubmed: 27085972
Dev Cell. 2013 Jun 10;25(5):492-506
pubmed: 23763948
Sci Transl Med. 2011 Dec 21;3(114):114rv3
pubmed: 22190240
Sci Rep. 2016 Oct 25;6:35754
pubmed: 27779198
Semin Cell Dev Biol. 2013 Mar;24(3):156-62
pubmed: 23270617
Blood. 2016 Jul 14;128(2):249-52
pubmed: 27207793
Mol Cell. 2010 Oct 22;40(2):294-309
pubmed: 20965423
Sci Signal. 2009 Feb 24;2(59):re1
pubmed: 19244214
Nat Rev Clin Oncol. 2011 Mar 01;8(4):210-21
pubmed: 21364524
ACS Chem Biol. 2010 Feb 19;5(2):245-53
pubmed: 20020776
Nat Med. 1995 Jan;1(1):27-31
pubmed: 7584949
Acta Ophthalmol. 2016 Dec;94(8):805-814
pubmed: 27255568
Dev Dyn. 2010 Nov;239(11):2806-12
pubmed: 20882680
Nature. 2006 Dec 21;444(7122):1032-7
pubmed: 17183313
Annu Rev Pathol. 2014;9:47-71
pubmed: 23937437
Dev Biol. 2008 Apr 15;316(2):312-22
pubmed: 18342303
Curr Ophthalmol Rep. 2017 Jun;5(2):136-140
pubmed: 29051844
Mol Vis. 2008 Jul 30;14:1358-72
pubmed: 18682809
Am J Pathol. 2011 Sep;179(3):1573-85
pubmed: 21827961
Endocrine. 2017 Aug;57(2):214-219
pubmed: 27481363
J Exp Med. 2017 Apr 3;214(4):1011-1027
pubmed: 28351983
Science. 2017 Aug 25;357(6353):
pubmed: 28775214
Prog Retin Eye Res. 2015 Nov;49:67-81
pubmed: 26113211
Am J Pathol. 2008 Oct;173(4):1173-85
pubmed: 18787105
J Clin Invest. 2006 Oct;116(10):2610-21
pubmed: 17016557
Dev Biol. 2005 Jun 1;282(1):55-69
pubmed: 15936329
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8234-E8243
pubmed: 28835536
Cancer Cell. 2002 Feb;1(1):99-108
pubmed: 12086892
N Engl J Med. 2005 Aug 25;353(8):782-92
pubmed: 16120858
Am J Transl Res. 2018 Aug 15;10(8):2372-2386
pubmed: 30210677
Bioorg Med Chem Lett. 2002 Dec 16;12(24):3537-41
pubmed: 12443771
Nat Commun. 2017 May 19;8:15492
pubmed: 28524872
Elife. 2015 Jun 08;4:
pubmed: 26051822
N Engl J Med. 2008 Jun 12;358(24):2606-17
pubmed: 18550876
Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6197-206
pubmed: 22915031
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11237-11242
pubmed: 27647901
BMC Dev Biol. 2015 Mar 27;15:18
pubmed: 25888280
Dev Cell. 2011 Mar 15;20(3):397-404
pubmed: 21397850
Nature. 2010 Apr 22;464(7292):1196-200
pubmed: 20364122
Dev Dyn. 2004 Nov;231(3):474-88
pubmed: 15376313
Nat Protoc. 2010 Dec;5(12):1903-10
pubmed: 21127484
Nature. 2007 Feb 15;445(7129):776-80
pubmed: 17259973
Ophthalmology. 2009 Oct;116(10 Suppl):S1-7
pubmed: 19800534
Cancer Cell. 2006 Nov;10(5):413-23
pubmed: 17097563
Neurobiol Aging. 2014 Nov;35(11):2562-2573
pubmed: 24925811
Biochem Soc Trans. 2014 Dec;42(6):1637-42
pubmed: 25399582
N Engl J Med. 2015 Mar 26;372(13):1193-203
pubmed: 25692915

Auteurs

Zaheer Ali (Z)

From the Division of Cardiovascular Medicine, Department of Medical and Health Sciences (Z.A., L.D.J.), Linkoping University, Sweden.

Anthony Mukwaya (A)

Division of Ophthalmology, Department of Clinical and Experimental Medicine (A.M., A.L., B.P., N.L.), Linkoping University, Sweden.

Antje Biesemeier (A)

Experimental Vitreoretinal Surgery, Center for Ophthalmology, University of Tuebingen, Germany (A.B., U.S.).

Maria Ntzouni (M)

Electronmicroscopy and Histology Laboratory, Faculty of Medicine (M.N.), Linkoping University, Sweden.

Daniel Ramsköld (D)

Department of Cell and Molecular Biology (D.R., S.G., R.S.), Karolinska Institutet, Stockholm, Sweden.

Sarantis Giatrellis (S)

Department of Cell and Molecular Biology (D.R., S.G., R.S.), Karolinska Institutet, Stockholm, Sweden.

Parviz Mammadzada (P)

Department of Clinical Neuroscience, Section for Ophthalmology and Vision, St. Erik Eye Hospital (P.M., A.K., H.A.), Karolinska Institutet, Stockholm, Sweden.

Renhai Cao (R)

Department of Microbiology, Tumor and Cell Biology (R.C., Y.C.), Karolinska Institutet, Stockholm, Sweden.

Anton Lennikov (A)

Division of Ophthalmology, Department of Clinical and Experimental Medicine (A.M., A.L., B.P., N.L.), Linkoping University, Sweden.

Michele Marass (M)

Department of Developmental Genetics, Max Planck Institute for Lung and Heart Research, Bad Nauheim, Germany (M.M., C.G.).

Claudia Gerri (C)

Department of Developmental Genetics, Max Planck Institute for Lung and Heart Research, Bad Nauheim, Germany (M.M., C.G.).

Camilla Hildesjö (C)

Division of Surgery, Orthopedics and Oncology, Department for Clinical and Experimental Medicine (C.H.), Linkoping University, Sweden.

Michael Taylor (M)

Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison (M.T.).

Qiaolin Deng (Q)

Department of Physiology and Pharmacology (Q.D., J.K.), Karolinska Institutet, Stockholm, Sweden.

Beatrice Peebo (B)

Division of Ophthalmology, Department of Clinical and Experimental Medicine (A.M., A.L., B.P., N.L.), Linkoping University, Sweden.

Luis Del Peso (L)

Department of Biochemistry, Universidad Autónoma de Madrid, Spain (L.d.P.).
Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain (L.d.P.).

Anders Kvanta (A)

Department of Clinical Neuroscience, Section for Ophthalmology and Vision, St. Erik Eye Hospital (P.M., A.K., H.A.), Karolinska Institutet, Stockholm, Sweden.

Rickard Sandberg (R)

Department of Cell and Molecular Biology (D.R., S.G., R.S.), Karolinska Institutet, Stockholm, Sweden.

Ulrich Schraermeyer (U)

Experimental Vitreoretinal Surgery, Center for Ophthalmology, University of Tuebingen, Germany (A.B., U.S.).

Helder Andre (H)

Department of Clinical Neuroscience, Section for Ophthalmology and Vision, St. Erik Eye Hospital (P.M., A.K., H.A.), Karolinska Institutet, Stockholm, Sweden.

John F Steffensen (JF)

Marine Biological Section, Biological Institute, University of Copenhagen, Helsingor, Denmark (J.F.S.).

Neil Lagali (N)

Division of Ophthalmology, Department of Clinical and Experimental Medicine (A.M., A.L., B.P., N.L.), Linkoping University, Sweden.

Yihai Cao (Y)

Department of Microbiology, Tumor and Cell Biology (R.C., Y.C.), Karolinska Institutet, Stockholm, Sweden.

Julianna Kele (J)

Department of Physiology and Pharmacology (Q.D., J.K.), Karolinska Institutet, Stockholm, Sweden.

Lasse Dahl Jensen (LD)

From the Division of Cardiovascular Medicine, Department of Medical and Health Sciences (Z.A., L.D.J.), Linkoping University, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH